C
Chromocell Therapeutics Corp
AMEX:CHRO
Chromocell Therapeutics Corp
AMEX:CHRO
Price:
22.46
USD
-5.03%
Market Closed
Market Cap:
$3.8m
Balance Sheet
Balance Sheet Decomposition
Chromocell Therapeutics Corp
Chromocell Therapeutics Corp
Balance Sheet Decomposition is not available for
Chromocell Therapeutics Corp
Chromocell Therapeutics Corp
Balance Sheet
Chromocell Therapeutics Corp
Chromocell Therapeutics Corp
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
1
|
|
| Cash |
0
|
0
|
0
|
0
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
1
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
0
+75%
|
1
+1 320%
|
|
| Liabilities | ||||||
| Accounts Payable |
3
|
3
|
3
|
5
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
1
|
1
|
2
|
|
| Total Current Liabilities |
4
|
3
|
4
|
7
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
1
|
0
|
0
|
0
|
|
| Total Liabilities |
4
N/A
|
4
+1%
|
4
+2%
|
7
+74%
|
4
-38%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
4
|
6
|
14
|
21
|
|
| Additional Paid In Capital |
0
|
0
|
2
|
7
|
19
|
|
| Total Equity |
4
N/A
|
4
-3%
|
4
-1%
|
6
-74%
|
3
+58%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
+75%
|
1
+1 320%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
6
|
6
|
6
|
6
|
6
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
